Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06288672 · ClinicalTrials.gov registry record · NA
IBS Skin Patch Test Food Allergy Study
A NA study of Irritable Bowel Syndrome, sponsored by IBS-80.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 2
- Study locations
NCT06288672 is a NA study of Irritable Bowel Syndrome that is actively recruiting participants, run by IBS-80. The registered enrollment target is 250 participants, above the 139-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (80% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT06288672, a NA study of Irritable Bowel Syndrome, is actively recruiting participants, sponsored by IBS-80.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 2
- Study locations
Study Summary
Participants with IBS are skin patch tested (no needles) to 80 different foods and food additives, compounded for patch testing, in search of food allergies. The testing requires 3 office visits within a 4 or 5 day period. The patches are taped to the back at Visit #. At Visit #2 48 hours later, the patches are removed from the skin and the outside border of each patch is marked with a felt tip marker. At Visit #3 (final visit) 1 or 2 days later, the patch test reading is performed by the doctor-investigator. An allergy is identified as a small red mark where the food was in contact with the skin for 48 hours. Those participants found to have food allergies are then placed on an avoidance diet (no calorie restriction) for 16 weeks where they either avoid eating the food(s) to which they are allergic (the \"true\" avoidance diet) or food(s) to which the testing did not show an allergy (this is called the \"sham\" avoidance diet). There is a 50/50 chance of going on either avoidance diet. The avoidance diet is assigned in such a way that neither the participant or the doctor-investigator knows which diet is being followed. After the 16 weeks, the participants answers a brief online questionnaire that asks about the IBS symptoms while following the avoidance diet. After the 16 week avoidance diet and final questionnaire are completed, those participants who were on the sham diet will be told of their true food allergies which they may try avoiding on their own.
Conditions Studied
Interventions
- OTHER True avoidance diet
- OTHER Sham avoidance diet
Study Locations (2)
Pennsylvania
- North Wales Dermatology, PLLC - North Wales
West Virginia
- Shepherd Allergy - Barboursville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2023-08-15 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06288672
The ClinicalTrials.gov registry entry for NCT06288672 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 139-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (80% higher). The listed sponsor is IBS-80, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Irritable Bowel Syndrome appearing as the primary indexed condition, and to 2 interventions - of which True avoidance diet is the first listed.
NCT06288672 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, West Virginia.
Frequently Asked Questions
What is clinical trial NCT06288672 about?
NCT06288672 is a clinical study titled "IBS Skin Patch Test Food Allergy Study". Participants with IBS are skin patch tested (no needles) to 80 different foods and food additives, compounded for patch testing, in search of food allergies. The testing requires 3 office visits within a 4 or 5 day period. The patches are taped to the back at Visit #. At Visit #2 48 hours later, the...
What is the current status of trial NCT06288672?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2023-08-15. Estimated completion is 2026-12.
What conditions does trial NCT06288672 study?
This clinical trial studies the following conditions: Irritable Bowel Syndrome.
What interventions are being tested in trial NCT06288672?
The interventions under investigation include: True avoidance diet (OTHER), Sham avoidance diet (OTHER).
Who is sponsoring clinical trial NCT06288672?
This trial is sponsored by IBS-80, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06288672 being conducted?
This trial has 2 study locations across Pennsylvania, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Irritable Bowel Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program?
RECRUITING · NA
-
GI Alpha-Gal Study
RECRUITING · NA
-
Visible Abdominal Distension
RECRUITING · NA
-
Standardized Yoga & Meditation Program for Stress Reduction for Adolescents With Irritable Bowel Syndrome
RECRUITING · NA
-
Well-being in IBS: Strengths and Happiness (WISH) 2.0
RECRUITING · NA
-
Mechanisms of Gulf War Illness
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.